Statin use and the risk of colorectal cancer in a population-based electronic health records study

There is extensive debate regarding the protective effect of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) on colorectal cancer (CRC). We aimed to assess the association between CRC risk and exposure to statins using a large cohort with prescription data. We carried out a case...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibáñez-Sanz, Gemma, Guinó, Elisabet, Pontes, Caridad, Quijada-Manuitt, Mª Ángeles, de la Peña-Negro, Luisa C, Aragón, María, Domínguez, Marga, Rodríguez-Alonso, Lorena, Blasco, Alex, García-Rodríguez, Ana, Morros, Rosa, Moreno, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753123/
https://www.ncbi.nlm.nih.gov/pubmed/31537841
http://dx.doi.org/10.1038/s41598-019-49877-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753123/
https://www.ncbi.nlm.nih.gov/pubmed/31537841
http://dx.doi.org/10.1038/s41598-019-49877-5

Ejemplares similares